Endovascular treatment for Moyamoya-associated intracranial aneurysms: a systematic review and meta-analysis
- 11 August 2025
- journal article
- review article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (7) , 1683-1689
Abstract
Background: Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of the distal internal carotid arteries, leading to increased collateral flow and the development of an abnormal vascular network, which imposes shear stress on small vessels and increases the risk of aneurysm formation. Endovascular treatment (EVT) has emerged as a potential approach for managing MMD-associated intracranial aneurysms (MMD-IA), but its safety and efficacy remain unclear. Objective: This systematic review and meta-analysis aimed to evaluate the safety, efficacy, and long-term outcomes of EVT in patients with MMD-IA. Methods: A comprehensive search was conducted across PubMed, Embase, and Web of Science, adhering to PRISMA guidelines. Studies reporting clinical and angiographic outcomes for EVT of MMD-IA were included. The primary outcomes were complete aneurysm occlusion, functional outcomes, procedural complications, and recurrence rates. Pooled analyses with 95% confidence intervals (95% CIs) were conducted, with heterogeneity assessed using I² statistics, and a random-effects model was applied. Results: Seventeen studies, comprising 506 patients (36.33% female; mean age: 49.24±10.91 years) with aneurysms were included. Of these, 181 patients underwent EVT. The pooled complete occlusion rate was 86.46% (95% CI: 39.28 to 98.44) immediately after embolization and 84.51% (95% CI: 75.67 to 90.54) at last follow-up. Procedure-related complications were 15.27% (95% CI: 9.88 to 22.85) and the prevalence of subarachnoid hemorrhage after the procedure was 5.25% (95% CI: 2.20 to 12.05). The prevalence of ischemic procedural complications was estimated at 8.69% (95% CI: 4.49 to 16.16). Functional independence (modified Rankin Scale (mRS) 0–2) was achieved in 86.93% (95% CI: 73.55 to 94.09) of cases at follow-up. The aneurysm recurrence rate was 8.08% (95% CI: 3.05 to 19.69), emphasizing the need for long-term monitoring. Conclusions: EVT appears to be a safe and effective treatment for MMD-IA, demonstrating high occlusion rates and favorable functional outcomes. However, the risk of aneurysm recurrence highlights the importance of long-term follow-up. Further large studies are necessary to confirm these findings and optimize treatment strategies for this complex condition.Keywords
This publication has 42 references indexed in Scilit:
- Risk factors of rupture and mortality for intracranial aneurysms associated with moyamoya disease: a multicenter retrospective studyNeurological Sciences, 2023
- Clinical features, surgical treatment, and outcome of intracranial aneurysms associated with moyamoya diseaseJournal of Clinical Neuroscience, 2020
- Location-based treatment of intracranial aneurysms in moyamoya disease: a systematic review and descriptive analysisNeurosurgical Review, 2020
- Pathogenesis of aneurysms on major vessels in moyamoya disease and management outcomeJournal of Clinical Neuroscience, 2019
- Ruptured Aneurysms of Collateral Vessels in Adult Onset Moyamoya Disease with Hemorrhagic PresentationClinical Neuroradiology, 2016
- Endovascular Treatment of Ruptured Large or Wide-Neck Basilar Tip Aneurysms Associated with Moyamoya Disease Using the Stent-Assisted Coil TechniqueJournal of Stroke and Cerebrovascular Diseases, 2015
- Disappearance of aneurysms associated with moyamoya disease after STA–MCA anastomosis with encephaloduro myosynangiosisJournal of Clinical Neuroscience, 2012
- Incidental major artery aneurysms in patients with non-hemorrhagic moyamoya diseaseActa Neurochirurgica, 2011
- Endovascular treatment of basilar tip aneurysms associated with moyamoya diseaseNeuroradiology, 2003
- Characteristics of intracranial aneurysms associated with moyamoya diseaseActa Neurochirurgica, 1996